HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Scientific Program 2025

Farid Moinfar
Keynote Presentation (In-Person)
Farid Moinfar, Ordensklinikum Linz Barmherzige Schwestern, Austria

Introduction: Basal-like breast carcinomas are immunohistochemically positive for basal-type keratins such as K 5/6, K14, and K17 and mostly are triple-negative (negativity for ER, PR, and Her2/neu). “Basal-like” or triple-negative breast carcinoma is mostly known as a distinct c… » Read More

Vandana Tiwari
Keynote Presentation (In-Person)
Vandana Tiwari, Dr. Ram Manohar Lohia Institute of Medical Sciences, India

Background: Oral squamous cell carcinoma (OSCC) is a leading malignancy with high mortality and poor prognosis. Dysregulation of endoplasmic reticulum stress response (ERSR) genes and circular RNAs (circRNAs) contributes to its tumorigenesis and progression. Aim: This study aimed… » Read More

Getachew Dagne
Oral Presentation (In-Person)
Getachew Dagne, University of South Florida, United States

Background: Examining spatial distribution of colorectal cancer (CRC) incidence or mortality is helpful for developing cancer control and prevention programs, or for generating hypotheses. Such an investigation involves describing the spatial variation of risk factors for colorec… » Read More

Namrata P Awasthi
Oral Presentation (In-Person)
Namrata P Awasthi, Dr. Ram Manohar Lohia Institute of Medical Sciences, India

Background: The lecture will introduce the audience to commonly utilized techniques for Cytology of malignant fluids including cytospin, cell block and immunohistochemistry. The advantages and limitations of the techniques will be discussed. Further, basics of flow cytometry (FCM… » Read More

Amir Ashraf
Oral Presentation (In-Person)
Amir Ashraf, Dr. Amir’s Family Homoeopathy Clinic, India

Homoeopathy is an alternative system of medicine discovered by German physician Samuel Hahnemann in 1796. It has been used by several people for various health conditions globally for more than last 200 years. In India, homoeopathy is considered as a major system of alternative m… » Read More

Zainab Awada
Oral Presentation (In-Person)
Zainab Awada, Sidra Medicine, Qatar

Background: Childhood acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, yet significant inter-individual variability exists in response to its therapy. Genetic polymorphisms as biomarkers for treatment efficacy and toxicity in childhood ALL are limited, part… » Read More

Shivam Singh
Oral Presentation (In-Person)
Shivam Singh, All India Institute of Medical Sciences, India

Background: The incidence of breast cancer has increased while the mortality rate has continued to remain high. Effective treatment of this disease is the key to survival. Therefore, this study is a necessity in continuing research into new effective treatments. According to anci… » Read More

Yuxin Zhu
Oral Presentation (In-Person)
Yuxin Zhu, Nanchang University, China

Pancreatic cancer (PC), characterized by aggressive progression and poor prognosis, poses a critical global health challenge. This multinational study investigates epidemiological disparities in PC incidence and disease burden through a socio-demographic index (SDI)-stratified an… » Read More

Redolen Rose Dhar
Oral Presentation (In-Person)
Redolen Rose Dhar, Manipal Academy of Higher Education, India

Background: Cancer is the leading cause of death worldwide, with the WHO projecting a 45% increase in global cancer deaths from 2008 to 2030 (1, 2). Beyond health impacts, cancer imposes significant economic strains, particularly on younger, low-income individuals (3). The extens… » Read More

Phyu Ou Maung
Oral Presentation (In-Person)
Phyu Ou Maung, University of Dental Medicine, Myanmar

Background: Oral squamous cell carcinoma (OSCC) has become a major oncologic problem. Survivin overexpression in OSCC could be associated with increased aggressiveness, poor response to chemotherapy and prediction of patient survival. This study was conducted to analyze the mRNA … » Read More

Changqin Pu
Oral Presentation (In-Person)
Changqin Pu, Peking Union Medical College Hospital, China

Objective: Pituitary adenomas (PAs) are clinically heterogeneous tumors with subtype-specific hormonal profiles, yet current therapies remain largely reactive and fail to address their proliferative core. This study challenges the dogma of subtype-driven tumorigenesis by identify… » Read More

Congcong Deng
Oral Presentation (In-Person)
Congcong Deng, Peking Union Medical College Hospital, China

Refractory pituitary adenomas (RPAs) and pituitary carcinomas (PCs) present significant therapeutic challenges, as they often do not respond to conventional treatment modalities such as surgery, radiation, and traditional medical therapies. Temozolomide (TMZ), an alkylating chemo… » Read More

Jian Li
Oral Presentation (In-Person)
Jian Li, Shanghai Jiaotong University, China

Conventional neoadjuvant chemotherapy offers limited benefit for patients with resectable non-small-cell lung cancer (NSCLC). Recently, neoadjuvant chemoimmunotherapy (NCIT) has transformed perioperative management of NSCLC by priming systemic anti-tumor immunity before surgery, … » Read More

Changjiang Yang
Oral Presentation (In-Person)
Changjiang Yang, Peking University People's Hospital, China

Recent research has linked Importin7 to cancer aggressiveness and a dismal prognosis, but its function in colorectal cancer (CRC) is unclear. This study aimed to elucidate the clinical relevance, biological function, and potential molecular mechanisms of IPO7 in CRC. Our results … » Read More

Pauline Picho Keronyai
Oral Presentation (In-Person)
Pauline Picho Keronyai, Nama Wellness Community Centre (NAWEC), Uganda

Cervical cancer remains a significant public health challenge in Africa, with the continent bearing approximately 19% of global cases. The East African region reports particularly concerning statistics, with an age-standardized incidence rate of 40.1 per 100,000 women annually, s… » Read More

Li Mian Er
Oral Presentation (In-Person)
Li Mian Er, The Fourth Hospital of Hebei Medical University, China

Objective:Endoscopic submucosal dissection (ESD) is widely used for early esophageal cancer,but the post-ESD stricture rate of patients with a post-ESD mucosal defect of ≥ 3/4 of the esophageal circumference is extremely high(even reach 90%).Long term repeated endoscopic dilat… » Read More

Chanchan Gao
Poster Presentation (In-Person)
Chanchan Gao, Zhongda Hospital, Southeast University, China

Objective: This study aimed to investigate the role of RGS2 in immune regulation and its impact on the efficacy of PD-1/PD-L1 blockade therapy in lung cancer (LC), as well as to explore the regulatory relationship between RGS2 and BATF2 in modulating T cell exhaustion and tumor i… » Read More

Yuchun Niu
Poster Presentation (In-Person)
Yuchun Niu, Oncology Hospital of the First People's Hospital of Foshan, China

Understanding the Role of Super-enhancer MYCNOS-SE in Chemoresistance of Small Cell Lung Cancer. Small cell lung cancer (SCLC) is a highly aggressive malignancy characterized by rapid progression and a high propensity for chemotherapy resistance. This presentation will discuss ou… » Read More

Jian Li
Poster Presentation (In-Person)
Jian Li, Shanghai Jiaotong University, China

Neoadjuvant immunotherapy with anti-programmed death-1 (neo-antiPD1) has revolutionized perioperative treatment for improving the overall survival (OS) of patients with early-stage lung cancer. Despite its transformative impact, neo-antiPD1 provides limited benefit to nearly 50% … » Read More

YouTube
WhatsAppWhatsApp